Literature DB >> 17345602

Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia.

Julie van der Zee1, Isabelle Le Ber, Sebastian Maurer-Stroh, Sebastiaan Engelborghs, Ilse Gijselinck, Agnès Camuzat, Nathalie Brouwers, Rik Vandenberghe, Kristel Sleegers, Didier Hannequin, Bart Dermaut, Joost Schymkowitz, Dominique Campion, Patrick Santens, Jean-Jacques Martin, Lucette Lacomblez, Tim De Pooter, Karin Peeters, Maria Mattheijssens, Martine Vercelletto, Marleen Van den Broeck, Marc Cruts, Peter P De Deyn, Frederic Rousseau, Alexis Brice, Christine Van Broeckhoven.   

Abstract

Null mutations in the progranulin gene (GRN, PGRN) were recently identified as the causal mechanism underlying frontotemporal dementia (FTD) with ubiquitin-positive brain pathology linked to chromosome 17 (FTDU-17). In a Belgian and French FTD series comprising 332 patients, we reported 13 PGRN null mutations which were mainly nonsense and frameshift mutations resulting in premature stop codons. Here we report in the same patient series three missense mutations of which two (c.743C>T, p.Pro248Leu and c.1294C>T, p.Arg432Cys) were predicted in silico to severely affect protein folding and/or processing leading to PGRN protein haploinsufficiency. In addition, we observed three sequence variations in the 5' regulatory region that might potentially affect PGRN transcription activity. Our findings extend the mutation spectrum in PGRN leading to loss of functional PGRN as the basis for FTD. Copyright 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17345602     DOI: 10.1002/humu.9484

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  40 in total

Review 1.  The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases.

Authors:  Konstanze F Winklhofer; Jörg Tatzelt; Christian Haass
Journal:  EMBO J       Date:  2008-01-23       Impact factor: 11.598

Review 2.  Update on recent molecular and genetic advances in frontotemporal lobar degeneration.

Authors:  Eileen H Bigio
Journal:  J Neuropathol Exp Neurol       Date:  2008-07       Impact factor: 3.685

Review 3.  Human genetics as a tool to identify progranulin regulators.

Authors:  Alexandra M Nicholson; NiCole A Finch; Rosa Rademakers
Journal:  J Mol Neurosci       Date:  2011-05-28       Impact factor: 3.444

Review 4.  Multifunctional molecule ERp57: From cancer to neurodegenerative diseases.

Authors:  Aubryanna Hettinghouse; Ronghan Liu; Chuan-Ju Liu
Journal:  Pharmacol Ther       Date:  2017-07-16       Impact factor: 12.310

Review 5.  The genetics of frontotemporal lobar degeneration.

Authors:  Rosa Rademakers; Mike Hutton
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

6.  Circulating progranulin as a biomarker for neurodegenerative diseases.

Authors:  Roberta Ghidoni; Anna Paterlini; Luisa Benussi
Journal:  Am J Neurodegener Dis       Date:  2012-08-02

Review 7.  Neurodegenerative dementia and parkinsonism.

Authors:  A Gabelle; F Portet; C Berr; J Touchon
Journal:  J Nutr Health Aging       Date:  2010-01       Impact factor: 4.075

8.  Missense mutations in progranulin gene associated with frontotemporal lobar degeneration: study of pathogenetic features.

Authors:  Celeste M Karch; Lubov Ezerskiy; Veronica Redaelli; Anna Rita Giovagnoli; Pietro Tiraboschi; Giuseppe Pelliccioni; Paolo Pelliccioni; Dimos Kapetis; Ilaria D'Amato; Elena Piccoli; Maria Giulia Ferretti; Fabrizio Tagliavini; Giacomina Rossi
Journal:  Neurobiol Aging       Date:  2015-11-02       Impact factor: 4.673

9.  Progranulin expression is upregulated after spinal contusion in mice.

Authors:  Swati B Naphade; Kristina A Kigerl; Lyn B Jakeman; Sandra K Kostyk; Phillip G Popovich; Jeff Kuret
Journal:  Acta Neuropathol       Date:  2009-11-28       Impact factor: 17.088

10.  Structure dissection of human progranulin identifies well-folded granulin/epithelin modules with unique functional activities.

Authors:  Dmitri Tolkatchev; Suneil Malik; Anna Vinogradova; Ping Wang; Zhigang Chen; Ping Xu; Hugh P J Bennett; Andrew Bateman; Feng Ni
Journal:  Protein Sci       Date:  2008-04       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.